The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arechiga, A. F.
Right arrow Articles by Walsh, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arechiga, A. F.
Right arrow Articles by Walsh, C. M.
The Journal of Immunology, 2005, 175: 7800-7804.
Copyright © 2005 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: FADD Is Not Required for Antigen Receptor-Mediated NF-{kappa}B Activation1

Adrian F. Arechiga*, Bryan D. Bell*, Jennifer C. Solomon*, Isaac H. Chu*, Claire L. Dubois*, Brian E. Hall{dagger}, Thaddeus C. George{dagger}, David M. Coder{dagger} and Craig M. Walsh2,*

* Center for Immunology and Department of Molecular Biology & Biochemistry, University of California, Irvine. CA 92697; and {dagger} Amnis Corporation, Seattle, WA 98121

Recently, it has been demonstrated that stimulated T cells bearing defects in caspase-8 fail to promote nuclear shuttling of NF-{kappa}B complexes. Such cells display strikingly similar proliferative and survival defects as T cells lacking Fas-associated death domain protein (FADD) function. We characterized NF-{kappa}B signaling in T cells bearing a dominant-negative FADD transgene (FADDdd). Whereas FADDdd T cells displayed proliferative defects following activation, these were not a consequence of aberrant NF-{kappa}B signaling, as measured by IKK/I{kappa}B phosphorylation and I{kappa}B degradation. There were no appreciable defects in nuclear translocation of p65/Rel using ImageStream, a flow-based imaging cytometer. Pretreatment with benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone, a potent caspase inhibitor, also failed to impede canonical NF-{kappa}B signaling. Secretion of IL-2 and up-regulation of various activation markers occurred normally. Thus, FADD does not play an essential role in NF-{kappa}B activation, suggesting an alternative route by which this adaptor promotes the clonal expansion of T cells.




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. F. Arechiga, B. D. Bell, S. Leverrier, B. M. Weist, M. Porter, Z. Wu, Y. Kanno, S. J. Ramos, S. T. Ong, R. Siegel, et al.
A Fas-Associated Death Domain Protein/Caspase-8-Signaling Axis Promotes S-Phase Entry and Maintains S6 Kinase Activity in T Cells Responding to IL-2
J. Immunol., October 15, 2007; 179(8): 5291 - 5300.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Wang, B. Grzywacz, D. Sukovich, V. McCullar, Q. Cao, A. B. Lee, B. R. Blazar, D. N. Cornfield, J. S. Miller, and M. R. Verneris
The unexpected effect of cyclosporin A on CD56+CD16 and CD56+CD16+ natural killer cell subpopulations
Blood, September 1, 2007; 110(5): 1530 - 1539.
[Abstract] [Full Text] [PDF]


Home page
Brief Funct Genomic ProteomicHome page
J. P. Nolan and L. Yang
The flow of cytometry into systems biology
Brief Funct Genomic Proteomic, July 4, 2007; (2007) elm011v1.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. L. Friedrich, M. Cui, J. B. Hernandez, B. M. Weist, H.-M. Andersen, X. Zhang, L. Huang, and C. M. Walsh
Modulation of DRAK2 Autophosphorylation by Antigen Receptor Signaling in Primary Lymphocytes
J. Biol. Chem., February 16, 2007; 282(7): 4573 - 4584.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
M. Lamkanfi, W. Declercq, T. Vanden Berghe, and P. Vandenabeele
Caspases leave the beaten track: caspase-mediated activation of NF-{kappa}B
J. Cell Biol., April 24, 2006; 173(2): 165 - 171.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.